315 related articles for article (PubMed ID: 28749399)
1. Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population.
Ballal S; Soundararajan R; Bal C
Indian J Med Res; 2017 Mar; 145(3):358-364. PubMed ID: 28749399
[TBL] [Abstract][Full Text] [Related]
2. Patterns of thyroid radioiodine uptake: Jordanian experience.
Al-Muqbel KM; Tashtoush RM
J Nucl Med Technol; 2010 Mar; 38(1):32-6. PubMed ID: 20159926
[TBL] [Abstract][Full Text] [Related]
3. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
4. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
5. Establishment of clinical diagnosis model of Graves' disease and Hashimoto's thyroiditis.
Cui Z; Wang Z; Liu X; Cai Y; Xu X; Yang T
J Transl Med; 2019 Jan; 17(1):11. PubMed ID: 30616573
[TBL] [Abstract][Full Text] [Related]
6. Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis.
Ohye H; Nishihara E; Sasaki I; Kubota S; Fukata S; Amino N; Kuma K; Miyauchi A
Intern Med; 2006; 45(6):385-9. PubMed ID: 16617190
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)].
Ikekubo K
Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915
[TBL] [Abstract][Full Text] [Related]
8. The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease.
Gemma R; Nakamura H; Mori T; Andoh S; Suzuki Y; Yoshimi T
Endocr J; 1996 Feb; 43(1):61-6. PubMed ID: 8732453
[TBL] [Abstract][Full Text] [Related]
9. The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels among patients with euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis versus healthy subjects.
Kilic MK; Yesilkaya Y; Tezcan K; Cinar N; Akin S; Karakaya J; Akata D; Usman A; Gurlek A
Endocr Res; 2016 May; 41(2):110-5. PubMed ID: 26726836
[TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume in euthyroid patients with Hashimoto's thyroiditis.
Carlioglu A; Timur O; Durmaz SA; Ayhan ME
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):282-4. PubMed ID: 25485785
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
[TBL] [Abstract][Full Text] [Related]
12. Correlation between iodine intake and thyroid disorders: a cross-sectional study from the South of China.
Zhao H; Tian Y; Liu Z; Li X; Feng M; Huang T
Biol Trace Elem Res; 2014 Dec; 162(1-3):87-94. PubMed ID: 25161089
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
14. Effect of lifelong iodine supplementation on thyroid 131-I uptake: a decrease in uptake in euthyroid but not hyperthyroid individuals compared to observations 50 years ago.
Milakovic M; Berg G; Eggertsen R; Nyström E
Eur J Clin Nutr; 2006 Feb; 60(2):210-3. PubMed ID: 16251883
[TBL] [Abstract][Full Text] [Related]
15. Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases.
Nishihara E; Amino N; Kudo T; Ito M; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Endocr J; 2017 Oct; 64(10):955-961. PubMed ID: 28768936
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice.
Nagayama Y; Nakahara M; Shimamura M; Horie I; Arima K; Abiru N
Clin Exp Immunol; 2012 Jun; 168(3):268-73. PubMed ID: 22519588
[TBL] [Abstract][Full Text] [Related]
17. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
[TBL] [Abstract][Full Text] [Related]
18. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
[TBL] [Abstract][Full Text] [Related]
19. [Clinical validity of anti-thyroperoxidase antibody and anti-thyroglobulin antibody].
Lian XL; Bai Y; Sun ML; Guo ZS; Dai WX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):677-81. PubMed ID: 15663231
[TBL] [Abstract][Full Text] [Related]
20. Correlation of radioiodine doses for 6-hr and 24-hour iodine-131 thyroid uptake values for Graves' hyperthyroidism.
Horn-Lodewyk J
Endocr J; 2019 Dec; 66(12):1047-1052. PubMed ID: 31391354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
